Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Accounts Payables (2016 - 2025)

CV Sciences (CVSI) has disclosed Accounts Payables for 14 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 45.77% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 45.77% year-over-year, with the annual reading at $1.0 million for FY2025, 45.77% down from the prior year.
  • Accounts Payables hit $1.0 million in Q4 2025 for CV Sciences, down from $1.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $2.7 million in Q1 2022 to a low of $646000.0 in Q2 2021.
  • Historically, Accounts Payables has averaged $1.9 million across 5 years, with a median of $2.2 million in 2022.
  • Biggest five-year swings in Accounts Payables: skyrocketed 282.82% in 2022 and later crashed 45.77% in 2025.
  • Year by year, Accounts Payables stood at $2.6 million in 2021, then dropped by 12.96% to $2.3 million in 2022, then increased by 1.09% to $2.3 million in 2023, then fell by 16.63% to $1.9 million in 2024, then plummeted by 45.77% to $1.0 million in 2025.
  • Business Quant data shows Accounts Payables for CVSI at $1.0 million in Q4 2025, $1.2 million in Q3 2025, and $1.4 million in Q2 2025.